Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Heart DiseaseCongestive Heart FailureAtrial Fibrillation
Interventions
DEVICE

Optimal Medical therapy plus ICD

DEVICE

Optimal Medical therapy plus CRT/ICD

Trial Locations (15)

Unknown

Libin Cardiovascular Institute of Alberta, Calgary

Vancouver General Hospital, Vancouver

St. Boniface General Hospital, Winnipeg

Queen Elizabeth II Health Science, Halifax

Hamilton Health Sciences, Hamilton

Kingston General Hospital, Kingston

St. Michael's General Hospital, Toronto

CHUM Centre hospitalier universitaire de Montréal, Montreal

McGill Health Science Centre, Montreal

Montreal Heart Institute, Montreal

Institut universitaire de cardiologie et de pneumologie de Quebec, Québec

Le Centre hospitalier universitaire de Sherbrooke, Sherbrooke

V8R 4R2

Victoria Cardiac Arrhythmia Trials, Victoria

N6A 5A5

London Health Sciences Centre, London

K1W 4W7

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Ottawa Heart Institute Research Corporation

OTHER

NCT01994252 - Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation | Biotech Hunter | Biotech Hunter